Citation: | XU Hongzhou, TAO Yanyan, LU Guoyu, WU Xiaofei. Application of lipoprotein a, fibrinogen and C-reactive protein in early diagnosis of coronary heart disease[J]. Chinese Journal of General Practice, 2024, 22(4): 548-550. doi: 10.16766/j.cnki.issn.1674-4152.003446 |
[1] |
GOULD K L, JOHNSON N P. A fundamental principle of coronary pathophysiology for risk stratifying coronary artery disease[J]. Eur Heart J-Card Img, 2021, 22(6): 647-649.
|
[2] |
FELDMAN D I, LATINA J, LOVELL J, et al. Coronary computed tomography angiography in patients with stable coronary artery disease[J]. Trends Cardiovasc Med, 2022, 32(7): 421-428. doi: 10.1016/j.tcm.2021.08.009
|
[3] |
GU J X, HUANG J, LI S S, et al. Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events[J]. Sci Rep, 2022, 12(1): 1-13. doi: 10.1038/s41598-021-99269-x
|
[4] |
张祥, 许宁, 甄晓玲, 等. 冠心病患者血清D-二聚体、脂蛋白相关磷脂酶A2与不规则趋化因子的表达及其对早期冠心病诊断的临床意义[J]. 实用预防医学, 2019, 26(9): 1142-1145. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYY201909034.htm
ZHANG X, XU N, ZHEN X L, et al. Expression of serum D-dimer, lipoprotein-associated phospholipase A2 and fractalkine in patients with coronary heart disease (CHD) and their clinical values in the diagnosis of early CHD[J]. Practical Preventive Medicine, 2019, 26(9): 1142-1145. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYY201909034.htm
|
[5] |
OLGA I A, ALEXANDRA V T, ELENA A K, et al. Lipoprotein(a), immune cells and cardiovascular outcomes in patients with premature coronary heart disease[J]. J Pers Med, 2022, 12(2): 269. DOI: 10.3390/jpm12020269.
|
[6] |
陶斯阳, 马晶茹. 代谢性炎症与冠心病发病机制研究的进展[J]. 沈阳医学院学报, 2023, 25(4): 337-340, 373. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYX202304001.htm
TAO S Y, MA J R. Progress in studying metabolic inflammation and the pathogenesis of coronary heart disease[J]. Journal of Shenyang Medical College, 2023, 25(4): 337-340, 373. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYX202304001.htm
|
[7] |
张艳达, 隋汝杰, 赵健, 等. 冠状动脉微循环障碍: 非阻塞性冠心病潜在发病机制[J]. 第二军医大学学报, 2020, 41(3): 315-320. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD202003015.htm
ZHANG Y D, SUI R J, ZHAO J, et al. Coronary microvascular dysfunction: the potential mechanism of non-obstructive coronary artery disease[J]. Journal of the Second Military Medical University, 2020, 41(3): 315-320. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD202003015.htm
|
[8] |
陈建华, 刘艳影. 冠心病患者CRP、PCT、SAA水平与冠状动脉粥样硬化程度的相关性分析[J]. 现代诊断与治疗, 2022, 33(2): 271-273, 290. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZD202202040.htm
CHEN J H, LIU Y Y. Correlation analysis between CRP, PCT, and SAA levels and coronary atherosclerosis degree in coronary artery disease[J]. Modern Diagnosis and Treatment, 2022, 33(2): 271-273, 290. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZD202202040.htm
|
[9] |
刘帅, 林闽江, 许亚飞. 冠状动脉CT血管造影定量分析预测冠心病患者心血管事件风险的价值[J]. 中华全科医学, 2019, 17(8): 1320-1322, 1407. doi: 10.16766/j.cnki.issn.1674-4152.000933
LIU S, LIN M J, XU Y F. The predictive value of coronary artery CTA quantitative indexes on long-term cardiovascular events in patients with coronary heart disease[J]. Chinese Journal of General Practice, 2019, 17(8): 1320-1322, 1407. doi: 10.16766/j.cnki.issn.1674-4152.000933
|
[10] |
GRAY A J, ROOBOTTOM C, SMITH J E, et al. Early computed tomography coronary angiography in adults presenting with suspected acute coronary syndrome: the RAPID-CTCA RCT[J]. Health Technol Assess, 2022, 26(37): 1-114. doi: 10.3310/IRWI5180
|
[11] |
WEI W Q, LI X, FENG Q, et al. LPA variants are associated with residual cardiovascular risk in patients receiving statins[J]. Circulation, 2018, 138(17): 1839-1849. doi: 10.1161/CIRCULATIONAHA.117.031356
|
[12] |
樊碧娆, 姚伟娟. 氧化型低密度脂蛋白受体在动脉粥样硬化发病机制中的作用[J]. 中国病理生理杂志, 2020, 36(10): 1897-1901. https://www.cnki.com.cn/Article/CJFDTOTAL-ZBLS202010024.htm
FAN B R, YAO W J. Role of receptors for oxidized low-density lipoprotein in pathogenesis of atherosclerosis[J]. The Chinese Journal of Pathophysiology, 2020, 36(10): 1897-1901. https://www.cnki.com.cn/Article/CJFDTOTAL-ZBLS202010024.htm
|
[13] |
贾曼华, 王国忠, 闫建颖, 等. 冠心病患者血清超敏C反应蛋白及脂蛋白相关磷脂酶A2水平与冠心病纤维脂质斑块纤维帽厚度的关系[J]. 中国介入心脏病学杂志, 2022, 30(5): 355-358. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJXB202205006.htm
JIA M H, WANG G Z, YAN J Y, et al. The relationship between serum hypersensitive C-reactive protein and lipoprorein-assoeiated phosPhohPaseA2 levels in patients with coronary heart disease and the thickness of fi brous cap of fibrolipid plaques in coronary heart disease[J]. Chinese Journal of Interventional Cardiology, 2022, 30(5): 355-358. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJXB202205006.htm
|
[14] |
邸云峰, 李德才, 张大勇. 血清锌指样转录因子2和脂蛋白相关磷脂酶A2水平与冠心病冠状动脉狭窄程度的相关性[J]. 中国临床研究, 2020, 33(7): 952-954, 958. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK202007020.htm
DI Y F, LI D C, ZHANG D Y. Correlation between serum Krüppel-like factor 2 and lipoprotein-associated phospholipase A2 levels and degree of coronary stenosisin patients with coronary heart disease[J]. Chinese Journal of Clinical Research, 2020, 33(7): 952-954, 958. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK202007020.htm
|
[15] |
DYKUN I, KAMPF J, RASSAF T, et al. Interaction between elevated lipoprotein(a) and LDL-cholesterol on mortality risk in patients with coronary artery disease[J]. Eur J Prev Cardiol, 2023, 30(13): 64-65. doi: 10.1093/eurjpc/zwad059
|
[16] |
KURL S, JAE S Y, VOUTILAINEN A, et al. The combined effect of blood pressure and C-reactive protein with the risk of mortality from coronary heart and cardiovascular diseases[J]. Nutr Metab Cardiovasc Dis, 2021, 31(7): 2051-2057. doi: 10.1016/j.numecd.2021.04.004
|
[17] |
WARD-CAVINESS C K, DE VRIES P S, WIGGINS K L, et al. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease[J]. PLoS One, 2019, 14(5): e0216222. DOI: 10.1371/journal.pone.0216222.
|
[18] |
于瑞杰, 徐敏. 冠心病患者D-二聚体、纤维蛋白原和超敏C反应蛋白的关系研究[J]. 医学检验与临床, 2023, 34(6): 21-24. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201412012.htm
YU R J, XU M. Research on relationship between the levels of D-dimer, fibrinogen and hypersensitivity C-reactive protein in patients with coronary heart disease[J]. Medical Laboratory Science and Clinics, 2023, 34(6): 21-24. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201412012.htm
|
[19] |
邹甜甜, 费安兴, 高淑珍, 等. 老年糖尿病合并冠心病病人MMP-9、D-D、Fib水平变化及临床意义[J]. 中西医结合心脑血管病杂志, 2018, 16(18): 2682-2685. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201818024.htm
ZOU T T, FEI A X, GAO S Z, et al. Changes and clinical significance of MMP-9、D-D、Fib levels in elderly patients with diabetes and coronary heart disease[J]. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease, 2018, 16(18): 2682-2685. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201818024.htm
|
[20] |
张瑾, 陶诗怡, 王子涵, 等. 纤维蛋白原与早发冠心病患病及早发冠心病痰湿证的关系[J]. 心脏杂志, 2023, 35(2): 177-182. https://www.cnki.com.cn/Article/CJFDTOTAL-XGNZ202302011.htm
ZHANG J, TAO S Y, WANG Z H, et al. The Relationship between Fibrinogen and Early Coronary Heart Disease and Phlegm Dampness Syndrome[J]. Chinese Heart Journal, 2023, 35(2): 177-182. https://www.cnki.com.cn/Article/CJFDTOTAL-XGNZ202302011.htm
|